The suspension, which may not exceed one year, and the withdrawal of the authorisation to open, provided for in article L. 5124-3, are decided by the Director General of the Agence nationale de sécurité du médicament et des produits de santé. These decisions may concern all or part of the authorised activity and may only be taken after the party concerned has been informed of the nature of the infringements observed and given formal notice to put an end to them within a specified period.
The decision to suspend or withdraw the authorisation is made public by the Director General of the Agency. Where the suspension or withdrawal of authorisation concerns a pharmaceutical establishment engaged in the wholesale, free transfer or wholesale distribution of medicinal products, the Director General of the Agence nationale de sécurité du médicament et des produits de santé shall inform the competent authorities of the Member States and the States party to the Agreement on the European Economic Area and the European Commission.